RTW Investments’s LakeShore Biopharma LSB Stock Holding History

RTW Investments’s Portfolio LSB Stock Details LSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,109	Closed	-$546K	–	69
2023 Q1	$546K	Buy	+34,109	New	+$1.73M	0.01%	58

Other funds holding LSB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VAM

Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

SLM

Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

FSI

Flow State Investments Chicago, Illinois $245M AUM 5.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RTW Investments's LSB Position: Q2 2023 in Review

RTW Investments sold out of LakeShore Biopharma (LSB) in Q2 2023, closing a stake of 34,109 shares — an estimated $546K sold.

RTW Investments first reported a position in LSB in Q1 2023 and held it in 1 quarter. The position peaked at $546K in Q1 2023. 16 funds tracked by Wall St. Rank hold LSB as of Q2 2023.

RTW Investments reported no remaining LakeShore Biopharma position as of Q2 2023 after selling out during the quarter.
RTW Investments sold 34,109 LakeShore Biopharma shares in Q2 2023, an estimated $546K.
RTW Investments first reported a position in LakeShore Biopharma in Q1 2023 and held it in 1 quarter.
RTW Investments's LakeShore Biopharma position peaked at $546K in Q1 2023.
16 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q2 2023.

Based on RTW Investments's 13F filing for Q2 2023, filed 14 Aug 2023.